Macrophages promote angiogenesis in human breast tumour spheroids in vivo

An in vivo model has been established to study the role of macrophages in the initiation of angiogenesis by human breast tumour spheroids in vivo. The extent of the angiogenic response induced by T47D spheroids implanted into the dorsal skinfold chamber in nude mice was measured in vivo and compared to that induced by spheroids infiltrated with human macrophages prior to implantation. Our results indicate that the presence of macrophages in spheroids resulted in at least a three-fold upregulation in the release of vascular endothelial growth factor (VEGF) in vitro when compared with spheroids composed only of tumour cells. The angiogenic response measured around the spheroids, 3 days after in vivo implantation, was significantly greater in the spheroids infiltrated with macrophages. The number of vessels increased (macrophages vs no macrophages 34±1.9 vs 26±2.5, P<0.01), were shorter in length (macrophages vs no macrophages 116±4.92 vs 136±6.52, P<0.008) with an increased number of junctions (macrophages vs no macrophages 14±0.93 vs 11±1.25, P<0.025) all parameters indicative of new vessel formation. This is the first study to demonstrate a role for macrophages in the initiation of tumour angiogenesis in vivo.

[1]  J. McGee,et al.  Macrophages in human breast disease: a quantitative immunohistochemical study. , 1988, British Journal of Cancer.

[2]  A. Griffioen,et al.  Angiogenic Profile of Breast Carcinoma Determines Leukocyte Infiltration , 2004, Clinical Cancer Research.

[3]  P. Borgström,et al.  Quantitative angiogenesis in a syngeneic tumor spheroid model. , 1995, Microvascular research.

[4]  B. Olsen,et al.  Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells. , 2001, Cancer research.

[5]  Noam Brown,et al.  The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.

[6]  D. Ribatti,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1998.0154 , 2022 .

[7]  R K Jain,et al.  Endothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Fox,et al.  TUMOUR ANGIOGENESIS , 1996, The Journal of pathology.

[9]  A. Mantovani,et al.  The origin and function of tumor-associated macrophages. , 1992, Immunology today.

[10]  Mihaela Skobe,et al.  Halting angiogenesis suppresses carcinoma cell invasion , 1997, Nature Medicine.

[11]  B. Zetter,et al.  Tumor interactions with the vasculature: angiogenesis and tumor metastasis. , 1990, Biochimica et biophysica acta.

[12]  M. Dewhirst,et al.  Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. , 2000, Journal of the National Cancer Institute.

[13]  R. Andreesen,et al.  Cytokine repertoire during maturation of monocytes to macrophages within spheroids of malignant and non‐malignant urothelial cell lines , 1998, International journal of cancer.

[14]  P. Borgström,et al.  Recombinant platelet factor 4, an angiogenic marker for human breast carcinoma. , 1998, Anticancer research.

[15]  F. Balkwill,et al.  Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation – a potential mechanism , 2001, European journal of immunology.

[16]  L. Akslen,et al.  Significance of tumour‐associated macrophages, vascular endothelial growth factor and thrombospondin‐1 expression for tumour angiogenesis and prognosis in endometrial carcinomas , 1999, International journal of cancer.

[17]  J. Nyhus,et al.  Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. , 2002, Cancer research.

[18]  M. Neeman,et al.  The role of angiogenesis, vascular maturation, regression and stroma infiltration in dormancy and growth of implanted MLS ovarian carcinoma spheroids , 2004, International Journal of Cancer.

[19]  J. Folkman Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[20]  J O McGee,et al.  Cytokine regulation of angiogenesis in breast cancer: the role of tumor‐associated macrophages , 1995, Journal of leukocyte biology.

[21]  R. Bjerkvig,et al.  Cells encapsulated in alginate: a potential system for delivery of recombinant proteins to malignant brain tumours , 1999, International Journal of Developmental Neuroscience.

[22]  N. Martinet,et al.  Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. , 2002, The Journal of laboratory and clinical medicine.

[23]  K. Messmer,et al.  Dorsal skinfold chamber technique for intravital microscopy in nude mice. , 1993, The American journal of pathology.

[24]  J. Beckstead,et al.  A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[25]  H. van Essen,et al.  Angiogenic potential of malignant and non‐malignant human breast tissues in an in vivo angiogenesis model , 1998, International journal of cancer.

[26]  A. Harris,et al.  Secretion of epidermal growth factor by macrophages associated with breast carcinoma , 1993, The Lancet.

[27]  H. Redmond,et al.  Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor β-1 , 1998, Annals of Surgical Oncology.

[28]  R. Jakesz,et al.  Tumour-associated macrophages in breast cancer and their prognostic correlations , 1998 .

[29]  A. Harris,et al.  Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.

[30]  H. Saji,et al.  Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  A. Harris,et al.  Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. , 2000, Cancer research.

[32]  K. Hillan,et al.  Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. , 1996, Cancer research.

[33]  C. Radzikowski,et al.  Cytotoxic cells in immunodeficient athymic mice. , 1994, Immunopharmacology and immunotoxicology.

[34]  C. Lewis,et al.  Comparison of three in vitro human ‘angiogenesis’ assays with capillaries formed in vivo , 2004, Angiogenesis.

[35]  G. Stamp,et al.  Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. , 1997, The American journal of pathology.

[36]  N. Brünner,et al.  Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. , 1993, Cancer research.

[37]  J. Soria,et al.  Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness , 2003, British Journal of Cancer.

[38]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[39]  J Folkman,et al.  Transplacental carcinogenesis by stilbestrol. , 1971, The New England journal of medicine.

[40]  R. Coombes,et al.  Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. , 1992, British Journal of Cancer.

[41]  P. Rogers,et al.  Macrophages and microvessel density in tumors of the ovary. , 1999, Gynecologic oncology.

[42]  J. Pollard,et al.  A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.

[43]  A. Harris,et al.  Expression of vascular endothelial growth factor by macrophages is up‐regulated in poorly vascularized areas of breast carcinomas , 2000, The Journal of pathology.